Widely used in peptide synthesis as a chiral building block, this compound enables the introduction of constrained cyclohexyl amino acid derivatives into peptide chains. Its stereochemistry supports the formation of specific secondary structures, making it valuable in the design of bioactive peptides with enhanced stability and selectivity. The Fmoc group allows for mild, base-labile protection during solid-phase synthesis, compatible with standard Fmoc-strategy protocols. It is particularly useful in medicinal chemistry for developing peptidomimetics and conformationally restricted analogs.